|
|
||||||||
CORRESPONDENCE: U. Costabel, Ruhrlandklinik, Dept Pneumology/Allergology, Tueschener Weg 40, 45239, Essen, Germany. Fax: 49 2014334029
Keywords: bronchoalveolar lavage, CD4/CD8 ratio, corticosteroids, Löfgren's syndrome, sarcoidosis
Received: March 8, 2001
Recent International Consensus Statement recommendations regarding diagnosis and therapy have been published. The diagnosis of sarcoidosis is based on a compatible clinical and/or radiological picture, histological evidence of noncaseating granulomas and exclusion of other diseases capable of producing a similar histological or clinical picture.
Therapy is based on corticosteroids, although there are indications of valuable alternatives. Except for life- and sight-threatening organ involvement, it should be carefully considered whether the patient might benefit from treatment. For asymptomatic pulmonary sarcoidosis, a watch and wait approach is appropriate; treatment should mainly be considered if symptoms develop or lung function deteriorates.
Many advances have been made regarding sarcoidosis in the past 2 decades. As a result, sarcoidosis is now defined as a multisystem disorder with a heightened cellular immune response at sites of disease activity in patients with a predisposition for sarcoidosis and a presumed exposure to as yet unknown transmissible environmental agents.
This article has been cited by other articles:
![]() |
B. J. Plant, S. Ghani, M. J. O'Mahony, L. Morgan, C. M. O'Connor, K. Morgan, J. A. Baugh, and S. C. Donnelly Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population Eur. Respir. J., February 1, 2007; 29(2): 325 - 329. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |